Breztri Aerosphere® is a prescription inhaler used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It combines three medications in one inhaler: a corticosteroid (budesonide), a long-acting beta2-agonist (formoterol fumarate), and a long-acting muscarinic antagonist (glycopyrrolate). This triple-action therapy helps reduce inflammation, relax airway muscles, and improve airflow—making it easier to breathe and reducing the risk of COPD flare-ups.

Features:

• Triple therapy in one device: Budesonide + Formoterol + Glycopyrrolate

• Helps reduce COPD exacerbations and improves lung function

• Used twice daily (morning and evening)

• Aerosphere® MDI technology for consistent delivery

• Built-in dose counter with 120 inhalations per canister